Cannabis has been used for centuries to treat nerves and anxiety, as well as other mood problems. CBD may help to improve both depression and anxiety, at least in part through its interactions with serotonin receptors in the brain. Research shows that CBD can reduce both mental and physical symptoms of anxiety. A study of CBD given to people before a public-speaking event indicates that CBD can help reduce stress—this and other research has shown that CBD can be an effective treatment for social anxiety.
Out of the 17 states that have passed CBD-only laws, five— Missouri, Florida, Mississippi, Louisiana, and Texas—would also establish licensed cultivation centers to grow high-CBD strains of cannabis, which could be turned into oils and other CBD products. This would cut down on the demand for CBD oil from unregulated manufacturers abroad. Even then, though, impediments remain. In Missouri, for example, two neurologists recently refused to prescribe CBD oil for an eight- year-old boy suffering from seizures, citing concerns over federal law and the safety of non-FDA approved products.
Anxiety subtypes: While the literature confers therapeutic efficacy of CBD for anxiety disorders, it doesn’t mention whether CBD may be more effective for certain subtypes of anxiety compared to others. Although most types of anxiety share commonalities, not all are the same nor exhibit the same underlying neural abnormalities. Therefore, it is logical to assume that CBD may provide greater benefit to those diagnosed with one type of anxiety (e.g. social phobia) than another (e.g. OCD).
Earlier preclinical studies have suggested that the therapeutic effects of CBD might depend on the presence of specific clinical conditions. As an example, Campos et al. (2013) showed that the chronic use of CBD for 2 weeks, while not directly increasing hippocampal neurogenesis, prevented its decrease by unpredictable chronic stress. Thus, the absence of changes in the sleep of healthy volunteers treated with CDB in our study should not be considered as a final indication that CBD could not have positive effects in patients with sleep disorders.
Research works in this aspect are inclining in the favor of CBD for alleviation of insomnia. For example, a study carried out in the year 2006 revealed that cannabidiol (CBD), which is the second important constituent of cannabis, and is non-psychoactive in nature, may have an impact on the sleep mechanism of rats. It was shown to increase alertness with light, and had no particular impact on sleep with the lights off. This provides an insight that CBD could be brought into use for therapeutic relief of day-time somnolence, and hence, can this way improve night-time sleep.
74. Deiana S, Watanabe A, Yamasaki Y. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Delta(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour. Psychopharmacology (Berl) 2012;219:859–873. doi: 10.1007/s00213-011-2415-0. [PubMed] [Cross Ref]
The following instruments were used: (a) Visual Analog Mood Scale – VAMS (Norris, 1971); (b) State-Trait Anxiety Inventory – STAI (Spielberger et al., 1970), translated and adapted to Brazilian Portuguese by Gorenstein and Andrade (1996); (c) Epworth Sleepiness Scale – ESS (Johns, 1991); (d) Pittsburgh Sleep Quality Index – PSQI (Buysse et al., 1989); (e) digit symbol substitution and symbol copying tests of the Wechsler (1955) Adult Intelligence Scale – WAIS; and (f) Psychomotor Vigilance Test – PVT (Graw et al., 2004; as made available by the National Center on Sleep Disorders Research).
A review published in 2017 in the journal Frontiers in Pharmacology described how CBD may work to protect the hippocampus — the part of the brain responsible for several important functions, such as learning, memory and navigation — during times of stress, and may also help prevent brain-cell destruction that results from schizophrenia. Another 2017 review published in the journal Annals of Palliative Medicine summarized a handful of studies that suggest cannabis oils containing THC or CBD, or both, may help with chronic pain management, but the mechanism is unclear.
Affiliate Disclosure: There are links on this site that can be defined as affiliate links. This means that I may receive a small commission (at no cost to you) if you purchase something when clicking on the links that take you through to a different website. By clicking on the links, you are in no way obligated to buy.
Medical Disclaimer: Statements in any video or written content on this site have not been evaluated by the FDA. If you are pregnant, nursing, taking medications, or have a medical condition, consult your physician before using this product. Representations regarding the efficacy and safety of CBD oil have not been evaluated by the Food and Drug Administration. The FDA only evaluates foods and drugs, not supplements like these products. These products are not intended to diagnose, prevent, treat, or cure any disease. The material on this site is provided for informational purposes only and is not medical advice. Always consult your physician before beginning any supplement program.
Copyright © thejoyfullotus.com